Genovis

18,92 SEK

1.631 følger denne virksomhed

GENO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genovis

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2021

EV/EBIT

Medianen 2019-2021

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)25,0031,5073,0045,9552,0024,7021,25
Aktier63,165,065,565,565,5169,466,1
Markedsværdi1.577,52.046,44.778,93.008,13.404,24.185,21.403,8
Enterprise value1.562,52.002,24.697,6----
EV/S25,832,850,5----
EV/EBITDA115,2233,6155,0----
EV/EBIT155,2637,7191,4----
P/E165,2317,5192,9241,855,349,459,0
P/B44,2923,4841,9223,9417,8418,365,17
P/S26,133,551,429,421,532,110,9
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio72,6 %81,7 %80,4 %83,5 %66,1 %69,6 %71,8 %
Gearing ratio------26,9 %